Oxford vaccine produces strong response in older adults, early data reveals
Hopes have been raised that the UK could produce a successful coronavirus vaccine after data from the University of Oxford showed its jab provokes a strong immune response in older people. The ChAdOx1 nCov-2019 vaccine, developed with pharmaceutical giant AstraZeneca, has been shown to trigger a robust immune response in healthy adults aged 56-69 and people over 70. Phase two data, published in The Lancet, suggests one of the groups most vulnerable to serious illness and death from Covid-19 could build immunity, researchers say.
The National - November 19, 2020View the full story here: https://www.thenational.scot/news/18883182.covid-oxford-vaccine-produces-strong-response-older-adults-early-data-reveals/